These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 701680

  • 1. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K, Matolon R, Wong PW.
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [Abstract] [Full Text] [Related]

  • 2. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
    Tremblay M, Bélanger L, Larochelle J, Privé L, Gagnon PM.
    Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
    [No Abstract] [Full Text] [Related]

  • 3. Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
    Watts RW, Chalmers RA, Liberman MM, Lawson AM.
    Pediatr Res; 1975 Dec; 9(12):875-8. PubMed ID: 1196703
    [Abstract] [Full Text] [Related]

  • 4. Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia.
    Suzuki Y, Konda M, Imai I, Imamura H, Shimao S, Okaka T.
    Int J Pediatr Nephrol; 1987 Dec; 8(3):171-6. PubMed ID: 3429140
    [Abstract] [Full Text] [Related]

  • 5. [Dietary management of hereditary tyrosinemia. Apropos of 7 cases].
    Jehan P, Buchman M, Odièvre M.
    Ann Pediatr (Paris); 1984 Jan; 31(1):33-40. PubMed ID: 6712098
    [No Abstract] [Full Text] [Related]

  • 6. Urinary p-tyramine in hereditary tyrosinemia: I. Levels as compared to normal individuals, effect of diet, and relationship to urinary tyrosine.
    Hoag GN, Hill A, Zaleski W.
    Clin Biochem; 1977 Feb; 10(1):24-5. PubMed ID: 837522
    [Abstract] [Full Text] [Related]

  • 7. The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat.
    Lock EA, Gaskin P, Ellis MK, Robinson M, Provan WM, Smith LL.
    Toxicol Appl Pharmacol; 1998 May; 150(1):125-32. PubMed ID: 9630461
    [Abstract] [Full Text] [Related]

  • 8. [Association, in the same subject, of deletion of the short arm of chromosome 4 (4p-) and of complete deficiency of parahydroxyphenyl-pyruvate oxidase activity in the liver (tyrosinosis)].
    Malpuech G, Mattei JF, Gaulme J, Palcoux JB, Lesec G, Vanlieferinghen P.
    J Genet Hum; 1981 Dec; 29(4):455-61. PubMed ID: 7328420
    [Abstract] [Full Text] [Related]

  • 9. [Hereditary tyrosinemia type III].
    Endo F.
    Ryoikibetsu Shokogun Shirizu; 1998 Dec; (18 Pt 1):137-40. PubMed ID: 9590008
    [No Abstract] [Full Text] [Related]

  • 10. A patient with tyrosinemia and hypermethioninemia.
    Partington MW, Haust MD.
    Can Med Assoc J; 1967 Oct 28; 97(18):1059-67. PubMed ID: 6050907
    [No Abstract] [Full Text] [Related]

  • 11. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F, Kitano A, Uehara I, Nagata N, Matsuda I, Shinka T, Kuhara T, Matsumoto I.
    Pediatr Res; 1983 Feb 28; 17(2):92-6. PubMed ID: 6828337
    [Abstract] [Full Text] [Related]

  • 12. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
    Hostetter MK, Levy HL, Winter HS, Knight GJ, Haddow JE.
    N Engl J Med; 1983 May 26; 308(21):1265-7. PubMed ID: 6188953
    [Abstract] [Full Text] [Related]

  • 13. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA.
    Scand J Clin Lab Invest Suppl; 1986 May 26; 184():27-34. PubMed ID: 3296130
    [Abstract] [Full Text] [Related]

  • 14. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
    Pelet B, Antener I, Faggioni R, Spahr A, Gautier E.
    Helv Paediatr Acta; 1979 May 26; 34(2):177-83. PubMed ID: 156708
    [Abstract] [Full Text] [Related]

  • 15. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N, Kinugasa A, Seo T, Ishii T, Ota T, Machida Y, Inoue F, Imashuku S, Kusunoki T, Takamatsu T.
    Pediatr Res; 1984 May 26; 18(5):463-6. PubMed ID: 6145143
    [Abstract] [Full Text] [Related]

  • 16. [Juvenile form of tyrosinemia type I].
    Nothjunge J, Rosendahl W.
    Klin Padiatr; 1989 May 26; 201(6):458-63. PubMed ID: 2601281
    [Abstract] [Full Text] [Related]

  • 17. [A rare cause of neonatal hyperphenylalaninemia: tyrosinemia type I].
    Sarles J, Maurin N, Giraud F.
    Pediatrie; 1992 May 26; 47(12):809-11. PubMed ID: 1338924
    [Abstract] [Full Text] [Related]

  • 18. Promising new treatment for type I tyrosinemia.
    Heubi JE.
    J Pediatr Gastroenterol Nutr; 1993 Oct 26; 17(3):340-1. PubMed ID: 8271141
    [No Abstract] [Full Text] [Related]

  • 19. Dietary restriction in inborn errors of amino acid metabolism.
    Bickel H.
    Curr Concepts Nutr; 1979 Oct 26; 8():35-53. PubMed ID: 527358
    [No Abstract] [Full Text] [Related]

  • 20. [Other abnormalities of tyrosine metabolism].
    Endo F.
    Ryoikibetsu Shokogun Shirizu; 1998 Oct 26; (18 Pt 1):144-5. PubMed ID: 9590010
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.